Clinical Trials Logo

Polycythemia clinical trials

View clinical trials related to Polycythemia.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT06033586 Enrolling by invitation - Polycythemia Vera Clinical Trials

Study to Evaluate the Long-term Safety of Rusfertide (PTG-300) in Subjects With Polycythemia Vera

THRIVE
Start date: January 22, 2024
Phase: Phase 3
Study type: Interventional

The goal of this clinical trial is to assess long-term safety and efficacy of rusfertide in subjects with polycythemia vera. Subjects who complete dosing with rusfertide until the end-of-treatment visit of a Phase 2 or Phase 3 study and meet the inclusion/exclusion criteria for this study, are eligible to participate in this open-label study and continue treatment with rusfertide.